DexCom, Inc. (DXCM)
Makes wearable sensors that track blood sugar levels for people with diabetes
$73.37+0.03%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-7.5%
The outlook
DexCom trades near the middle of its 52-week range with strong analyst backing—25 analysts rate it Strong Buy, and the average price target sits about 17% above current levels. The stock is positioned above both its 50- and 200-day moving averages, reflecting a sustained uptrend. At a trailing P/E of 30.7, it carries a premium valuation typical of growth-focused healthcare companies.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 25 analysts
Price trendAbove its 50- & 200-day averages
52-week range54% of the way from its 52-week low to high
Price targetAvg target +17% vs current price
Analyst price target
~12-month · 25 analysts$86.12average target+17.4% vs now
Now $73.37
Low $65.00High $112.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$28.31B
52-wk high
$89.98
52-wk low
$54.11
50-day avg
$72.00
200-day avg
$67.54
Trailing P/E
30.7